Shandong New Time Pharmaceutical Co., Ltd.
FDA inspection history in Linyi, China, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Linyi, China.
Cited most
Across all Shandong New Time Pharmaceutical Co. observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
The complete Shandong New Time Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Linyi, China
One Form 483 · 2024 · 2 observations
Latest: Form 483, Jul 9, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-07-09 | 483 Form 483 | Linyi, China | 2 | $99 |
FEI number 3006704412 · most recent document Jul 9, 2024
About Shandong New Time Pharmaceutical Co., Ltd.
How many FDA Form 483s has Shandong New Time Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Shandong New Time Pharmaceutical Co., Ltd.; the most recent is dated Jul 9, 2024.
When was Shandong New Time Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shandong New Time Pharmaceutical Co., Ltd. is a Form 483 dated Jul 9, 2024, for the site in Linyi, China.
What did FDA cite at Shandong New Time Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Shandong New Time Pharmaceutical Co., Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time.